Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
Publication
, Journal Article
Lyman, GH
Published in: Cancer Invest
July 2009
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
July 2009
Volume
27
Issue
6
Start / End Page
593 / 597
Location
England
Related Subject Headings
- Treatment Outcome
- Research Support as Topic
- Randomized Controlled Trials as Topic
- Predictive Value of Tests
- Population Surveillance
- Patient Selection
- Oncology & Carcinogenesis
- Neoplasms
- Models, Theoretical
- Medical Oncology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H. (2009). Comparative effectiveness research in oncology: the need for clarity, transparency and vision. Cancer Invest, 27(6), 593–597. https://doi.org/10.1080/07357900903109952
Lyman, Gary H. “Comparative effectiveness research in oncology: the need for clarity, transparency and vision.” Cancer Invest 27, no. 6 (July 2009): 593–97. https://doi.org/10.1080/07357900903109952.
Lyman GH. Comparative effectiveness research in oncology: the need for clarity, transparency and vision. Cancer Invest. 2009 Jul;27(6):593–7.
Lyman, Gary H. “Comparative effectiveness research in oncology: the need for clarity, transparency and vision.” Cancer Invest, vol. 27, no. 6, July 2009, pp. 593–97. Pubmed, doi:10.1080/07357900903109952.
Lyman GH. Comparative effectiveness research in oncology: the need for clarity, transparency and vision. Cancer Invest. 2009 Jul;27(6):593–597.
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
July 2009
Volume
27
Issue
6
Start / End Page
593 / 597
Location
England
Related Subject Headings
- Treatment Outcome
- Research Support as Topic
- Randomized Controlled Trials as Topic
- Predictive Value of Tests
- Population Surveillance
- Patient Selection
- Oncology & Carcinogenesis
- Neoplasms
- Models, Theoretical
- Medical Oncology